Skip to content
Search

Latest Stories

Yorkshire suspend coach Gale for historical tweet

Yorkshire suspend coach Gale for historical tweet
Easterneye.Biz Staff
By Easterneye.Biz StaffNov 10, 2021
Easterneye.Biz Staff
See Full Bio

YORKSHIRE have suspended coach Andrew Gale as part of an investigation into a tweet he sent in 2010, the club said in a statement on Tuesday (9).

Yorkshire, which has been rocked by allegations of institutional racism at the club made by former player Azeem Rafiq, added that director of cricket Martyn Moxon was absent from work due to a "stress-related illness".

"We can confirm that Andrew Gale, Yorkshire First XI Coach, is currently suspended pending a disciplinary hearing following an historic tweet," Yorkshire said in a statement. The Jewish News reported that Gale, then club captain, sent a tweet containing an anti-Semitic slur.

Gale told the Jewish News he was “completely unaware” of the offensive nature of the term when he sent the message, which was deleted soon after it was posted.

Yorkshire also confirmed that the club had shared a copy of the report looking into the allegations made by Rafiq with England's Department for Digital, Culture, Media & Sport.

azeem rafiqyorkshire

Related News

Madhun Foolchand
News

Madhun Foolchand’s new book exposes racism in NHS

What are the Key Features of a Health Insurance Member Portal?
Sponsored Feature

What are the Key Features of a Health Insurance Member Portal?

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Asian Media Group USA Inc
Contact Us